A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma

被引:14
|
作者
Santos, Gilda da Cunha [1 ,2 ]
Wyeth, Tyler [2 ]
Reid, Allie [2 ]
Saieg, Mauro Ajaj [3 ]
Pitcher, Bethany [4 ,5 ]
Pintilie, Melania [4 ,5 ]
Kamel-Reid, Suzanne [1 ,2 ]
Tsao, Ming Sound [1 ,2 ]
机构
[1] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, 200 Elizabeth St,11th Floor,Eaton Wing, Toronto, ON M5G 2C4, Canada
[3] Santa Casa Med Sch, Dept Pathol, Sao Paulo, Brazil
[4] Univ Hlth Network, Dept Biostat, Toronto, ON, Canada
[5] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
关键词
GROWTH-FACTOR RECEPTOR; CYTOLOGICAL SPECIMENS; CANCER PATIENTS; KRAS MUTATIONS; GENE ANALYSIS; EXPERIENCE; SAMPLES; SMEARS;
D O I
10.1136/jclinpath-2015-203437
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims Different approaches have been described for reporting specimen adequacy for epidermal growth factor receptor (EGFR) mutation analysis. We aimed: (1) to conduct cellularity assessment and to investigate its association with DNA yield, (2) to compare the H&E slides taken before and after the thick sections (curls) obtained for EGFR testing and (3) to evaluate the number of ancillary studies performed. Methods Cell block (CB) slides of 110 non-small cell lung carcinoma cases submitted to EGFR analysis from 2010 to 2012 were reviewed for total cellularity (ranges 1-100, 100-250, 250-500, 500-750, 750-1000 and > 1000 cells), tumour cellularity (ranges 1-50, 50-100, 100-300 and > 300 cells) and the percentage of tumour cells. Precurl and postcurl H&E slides were compared using the three criteria. The number of immunohistochemistry (IHC) markers and special stains and DNA yield were recorded. Results DNA yield was significantly associated with the total cellularity, number and percentage of tumour cells. For 46 cases with precurl and postcurl slides, only three (6.5%) were classified as being different and in two of them the postcurl slide had greater cellularity than the precurl. IHC was performed in 83 cases, with a minimum of 1 and a maximum of 11 markers (median of 3) per case. Conclusions An association between the total cellularity and the tumour cellularity with the DNA yield was demonstrated using the ranges described. Evaluation of a postcurl slide is an unnecessary practice. The majority of the CB had sufficient material for ancillary studies (up to 11 markers) and mutation testing.
引用
收藏
页码:607 / 611
页数:5
相关论文
共 50 条
  • [31] CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer
    Giorgio Maria Agazzi
    Marco Ravanelli
    Elisa Roca
    Daniela Medicina
    Piera Balzarini
    Carlotta Pessina
    William Vermi
    Alfredo Berruti
    Roberto Maroldi
    Davide Farina
    La radiologia medica, 2021, 126 : 786 - 794
  • [32] Identification of EGFR mutations in cytological specimens of non-small cell lung carcinoma from a single institute
    Wang, Weiya
    Tang, Yuan
    Li, Jinnan
    Zhang, Yuan
    Zou, Yan
    Su, Xueying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (02): : 929 - 935
  • [33] Major Pathologic Response in Patients Treated for Non-small Cell Carcinoma of the Lung: Is There a Magic Number in the Histologic Sections to Be Evaluated?
    Oramas, Diana M.
    Moran, Cesar A.
    ADVANCES IN ANATOMIC PATHOLOGY, 2021, 28 (02) : 67 - 71
  • [34] A novel EGFR inhibitor SP101 blocks survivin and tumor growth in the human non-small cell lung carcinoma
    Chao, Jui-I
    Wang, Su-Pei
    Wu, Ya-Hui
    Yang, Jinn-Moon
    Chen, Chinpiao
    FASEB JOURNAL, 2015, 29
  • [35] Clinicopathological features of non-small cell lung cancer in south India and correlation with epidermal growth factor receptor [EGFR] mutational status
    Bhatt, A. D.
    Pai, R.
    Rebekah, G.
    Dhananjayan, S.
    ArunNehru, G.
    Samuel, A.
    Singh, A.
    Joel, A.
    Korula, A.
    Chacko, R. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S832 - S833
  • [36] EGFR MUTATION ASSESSMENT FROM FIXED AND FRESH CYTOLOGICAL MATERIAL IN NON-SMALL CELL LUNG CANCER
    Szumera-Cieckiewicz, Anna
    Tysarowski, Andrzej
    Grodzki, Michal W.
    Kowalski, Dariusz M.
    Glogowski, Maciej
    Siedlecki, Janusz A.
    Olszewski, Wlodzimierz T.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S732 - S733
  • [37] Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction
    S. Mitani
    H. Kamata
    M. Fujiwara
    N. Aoki
    T. Tango
    K. Fukuchi
    T. Oka
    Clinical and Experimental Medicine, 2001, 1 : 105 - 111
  • [38] Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction
    Mitani, S
    Kamata, H
    Fujiwara, M
    Aoki, N
    Tango, T
    Fukuchi, K
    Oka, T
    CLINICAL AND EXPERIMENTAL MEDICINE, 2001, 1 (02) : 105 - 111
  • [39] EGFR Mutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry
    Sholl, Lynette M.
    Xiao, Yun
    Joshi, Victoria
    Yeap, Beow Y.
    Cioffredi, Leigh-Anne
    Jackman, David M.
    Lee, Charles
    Jaenne, Pasi A.
    Lindeman, Neal I.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (06) : 922 - 934
  • [40] Evaluation of adjunct immunohistochemistry on reporting patterns of non-small cell lung carcinoma diagnosed histologically in a regional pathology centre
    McLean, E. C.
    Monaghan, H.
    Salter, D. M.
    Wallace, W. A.
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (12) : 1136 - 1138